Invivoscribe, a leader in precision medicine and measurable residual disease (MRD) testing, today announced the addition of the LeukoStrat® KMT2A + MRD Assay and Software to its industry-leading ...
MASI targets 7%-10% revenue growth through 2028, sharp margin expansion and rising cash flow as intelligent monitoring and ...
Introduction Mobile health (mHealth) technologies have become increasingly popular for monitoring mental health symptoms and lifestyle behaviours, and are largely reported to be feasible and ...
Q3 2026 Sales/Trading Call February 4, 2026 2:00 AM ESTCompany ParticipantsPierre Barnabé - CEO & DirectorAlbin Jacquemont - ...
Amgen (NASDAQ: AMGN) today announced financial results for the fourth quarter and full year of 2025 versus the ...
Ad hoc announcement pursuant to Art. 53 LR Full year Net sales grew +8% (cc1, +8% USD) with core operating income1 up +14% (cc, +12% USD) Sales growth driven by continued strong performance ...
Sales growth driven by continued strong performance from priority brands including Kisqali (+57% cc), Kesimpta (+36% cc), Pluvicto (+42% cc), Scemblix (+85% cc) and Cosentyx (+8% cc) Core operating ...
Discover the key differences between Data Science, Data Engineering, and AI. Learn about their unique roles, technical ...
Globally, there are more than 650,000 newly diagnosed cases of bladder cancer annually, with up to approximately 80% of these ...
Disrupting left superior frontal sulcus selectively impaired perceptual but not value-based decisions, revealing segregated ...
Scientists surveyed said that electronic lab notebooks often fail in fundamental research tasks, including recording and ...
Mild traumatic brain injury (mTBI) remains a significant health concern for the US Military Health System and a threat to warfighter readiness. Although most service members (SMs) recover following an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results